EU Commission Updates Guidance on SARS-CoV-2 Test Classification
The In Vitro Diagnostic (IVD) expert panel of the European Commission has released new scientific advice regarding SARS-CoV-2. The panel notes that, while the virus can still cause serious illness, it no longer poses a life-threatening risk with a significant mortality rate for the general European population.
This updated assessment may influence the classification of SARS-CoV-2 tests under Regulation (EU) 2017/746. Manufacturers are encouraged to:
- Evaluate how this advice impacts their devices.
- Consult with their notified bodies to determine necessary conformity assessment steps if a change in risk class is warranted.
In the interim, devices can continue to be marketed under their current risk classification, provided they meet all necessary requirements for that class, such as batch testing in accordance with Article 100(2)(b) of Regulation (EU) 2017/746.
The Medical Device Coordination Group (MDCG) is updating its guidance on IVD classification (MDCG 2020-16) to reflect this new advice. It's important to note that both the expert panel's advice and the MDCG classification guidance are not legally binding. Manufacturers should determine each device's risk classification on a case-by-case basis, considering the device’s intended purpose and target population. Additionally, the panel's advice pertains to the current epidemiological context, and manufacturers should consider any changes in this context when evaluating the classification of their tests.
For detailed information, please refer to the official announcement: https://health.ec.europa.eu
MedNet EC-REP GmbH remains committed to keeping our clients informed about regulatory updates that may impact their products. We encourage manufacturers to review this new guidance and assess its implications for their devices.
Latest news
EU eIFU Regulation Update Draft: What Medical Device Professionals Need to Know
The European Commission has introduced a significant amendment to Implementing Regulation (EU) 2021/2226, impacting how medical device manufacturers provide instructions for use (IFU).
Understanding the Interplay: MDR, IVDR, and the AI Act – Key Insights from MDCG 2025-6
Recently, the MDCG, in conjunction with the Joint Artificial Intelligence Board (AIB), released the MDCG 2025-6 FAQ document, offering essential clarifications on the interplay between the MDR, the IVDR, and the Artificial Intelligence Act (AIA).
Navigating IVDR and MDR Performance Studies: Key Insights from MDCG 2025-5 Q&A
The European Medical Device Coordination Group (MDCG) has released its latest guidance, MDCG 2025-5, a comprehensive Questions & Answers document addressing performance studies for in vitro diagnostic medical devices (IVDs) under Regulation (EU) 2017/746 (IVDR).
MDCG 2019-11 Rev.1: Important Changes for Medical Device Software Developers
In the dynamic world of medical device regulation, staying abreast of the latest guidance is paramount for manufacturers. The Medical Device Coordination Group (MDCG) has recently released a significant update to its MDCG 2019-11 guidance document, now designated as MDCG 2019-11 Rev.1.
MDCG 2025-4: Key Guidance for Medical Device Software on Online Platforms
The European Commission's Medical Device Coordination Group (MDCG) has released the MDCG 2025-4 guidance document, titled "Guidance on the safe making available of medical device software (MDSW) apps on online platforms."
New MIR Form 7.3.1: Key Update for Incident Reporting under EU MDR
The European Commission has released a new version of the Manufacturer Incident Report (MIR) form which will become mandatory for all medical device manufacturers from November 2025.
EUDAMED Workshop: Essential Training for Medical Device Stakeholders
The European Commission is hosting a free, hybrid EUDAMED workshop in Stuttgart on May 21, 2025, designed to support the onboarding of all actors involved with the European Database on Medical Devices (EUDAMED).
EU Expands Harmonised Standards for MDR: Focus on Medical Gloves, Sterilisation, and Patient Transport Equipment
The European Commission has taken a significant step in strengthening the regulatory framework for medical devices by harmonising additional standards under the MDR.